Table 2. Correlation of butyrylcholinesterase activity within young patients and remaining age strata.
| Young patients (45–64 years) | Middle-aged and old patients (65–100 years) | ||||||
|---|---|---|---|---|---|---|---|
| values | p = | r = | values | p = | r = | p = * | |
| Butyrylcholinesterase, kU/l (IQR) | 7.2 (5.9–8.6) | 6.2 (5.4–7.5) | <0.001 | ||||
| LHD (max), U/l (IQR) | 455.0 (294.0–753.0) | 0.968 | -0.003 | 444.5 (296.0–655.0) | 0.216 | 0.061 | 0.367 |
| CK (max), U/l (IQR) | 950.0 (320.8–1752.5) | 0.278 | 0.076 | 587.5 (225.3–1515.0) | <0.001 | 0.207 | 0.003 |
| Troponin T (max), μg/l (IQR) | 2.2 (0.7–4.9) | 0.529 | -0.044 | 2.2 (0.8–4.9) | 0.161 | 0.069 | 0.957 |
| Gamma-GT μkat/l (IQR) | 30.5 (20.0–53.8) | 0.001 | 0.238 | 28.0 (18.0–48.0) | 0.108 | 0.069 | 0.437 |
| Quick Test % (IQR) | 96.0 (82.3–109.8) | 0.014 | 0.171 | 89.0 (75.0–101.0) | <0.001 | 0.196 | <0.001 |
| Fibrinogen mg/dl (IQR) | 388.5 (325.5–457.5) | 0.003 | 0.204 | 421.0 (356.0–496.0) | 0.280 | -0.053 | <0.001 |
| Age, years (IQR) | 54.3 (47.4–59.5) | 0.055 | 0.134 | 84.4 (73.1–87.3) | <0.001 | -0.290 | <0.001 |
| Body mass index, kg/m2 (IQR) | 28.1 (24.9–31.7) | <0.001 | 0.252 | 25.3 (23.4–27.7) | <0.001 | 0.185 | <0.001 |
| AST, U/l (IQR) | 38.0 (24.0–98.0) | 0.216 | -0.086 | 49.0 (29.0–106.0) | 0.393 | -0.042 | 0.035 |
| ALT, U/l (IQR) | 27.0 (19.0–46.0) | 0.113 | 0.110 | 27.0 (17.0–44.0) | 0.037 | -0.103 | 0.191 |
| Total Bilirubin, μmol/l (IQR) | 0.49 (0.35–0.70) | 0.057 | -0.134 | 0.62 (0.46–0.91) | 0.001 | -0.168 | <0.001 |
| Median BChE values (IQR) within | Yes | No | Yes | No | p = ** | ||
| Resuscitation before angiography | 6.7 (5.3–7.5) | 7.3 (5.9–8.7) | 6.3 (5.1–8.0) | 6.2 (5.5–7.4) | 0.747 | ||
| Hypertension | 7.5 (5.9–9.1) | 6.8 (5.3–8.0) | 6.2 (5.4–7.5) | 6.3 (5.5–7.4) | <0.001 | ||
| Diabetes mellitus | 8.2 (6.4–9.5) | 7.1 (5.9–8.4) | 6.4 (5.2–7.3) | 6.2 (5.5–7.7) | <0.001 | ||
| Hypercholesterolemia | 7.3 (5.9–9.1) | 6.8 (5.9–8.4) | 6.4 (5.5–7.8) | 6.1 (5.1–7.1) | <0.001 | ||
| Current smoker | 7.3 (5.9–8.7) | 6.7 (5.9–8.5) | 6.3 (5.6–7.4) | 6.2 (5.4–7.5) | <0.001 | ||
| Family history of CVD | 7.2 (6.1–8.7) | 7.2 (5.8–8.5) | 6.1 (5.3–7.3) | 6.3 (5.5–7.5) | <0.001 | ||
| STEMI | 7.4 (6.1–8.7) | 6.7 (5.4–8.4) | 6.2 (5.4–7.5) | 6.6 (5.8–7.8) | <0.001 | ||
| Coronary intervention | 7.3 (5.9–8.7) | 6.9 (5.0–8.4) | 6.5 (5.6–7.9) | 6.1 (5.2–6.9) | <0.001 | ||
| Fibrinolysis | 6.5 (4.8–8.6) | 7.3 (6.1–8.6) | 5.8 (5.2–7.6) | 6.3 (5.5–7.5) | 0.759 | ||
| Gender (male) | 7.2 (5.9–8.5) | 7.3 (5.9–8.6) | 6.3 (5.5–7.7) | 6.2 (5.3–7.4) | 0.001 |
Continuous data are presented as median (interquartile range) and their association with butyrylcholinesterase was assessed using Spearman–Rho correlation coefficient. Median butyrylcholinesterase values are demonstrated within categorical data and were analyzed using Mann-Whitney-U test
* P-value for comparison of median values within young patients and the remaining age strata using Mann-Whitney-U test
** P-values for comparison of median butyrylcholinesterase values within categorical variables in young patients and the remaining age strata using Mann-Whitney-U test